Join us for an engaging and informative session exploring the challenges and advancements in managing cisplatin-induced ototoxicity in pediatric oncology. With insights from leading experts, this webinar will delve into the latest approaches to otoprotection, discussing patient-specific adaptations, clinical efficacy, and associated risks.
Date: 11 April, 2025 | 15:00–16:30 (CET)
Time | Topic | Presenter |
15:00–15:05 | Introduction | - |
15:05–15:25 | Adaptations to the Pediatric Reality | Dr. Alex Hoetink (PMC) |
15:25–15:35 | Q&A and Discussion | - |
15:35–15:55 | Tbd | Prof. Marry Van den Heuvel-Eibrink (PMC) |
15:55–16:15 | Otoprotection: Efficacy and Risks | Prof. Peppy Brock (GOSH) |
16:15–16:30 | Q&A and Discussion | - |
This webinar is for healthcare professionals working in pediatric oncology, otolaryngology, or audiology, offering valuable knowledge and practical insights.
Registration is mandatory and will open soon.
Accreditation has been requested.
This event is made possible thanks to our sponsor, Norgine.